Yanni Wang

5.7k total citations · 2 hit papers
186 papers, 3.7k citations indexed

About

Yanni Wang is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, Yanni Wang has authored 186 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 24 papers in Immunology and 23 papers in Nephrology. Recurrent topics in Yanni Wang's work include Chronic Kidney Disease and Diabetes (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Yanni Wang is often cited by papers focused on Chronic Kidney Disease and Diabetes (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Yanni Wang collaborates with scholars based in China, United States and Canada. Yanni Wang's co-authors include Ying‐Yong Zhao, Gang Cao, He-He Hu, Dan‐Qian Chen, Nosratola D. Vaziri, Ya‐Long Feng, Hua Miao, Xiaqing Wu, Xiao-Yong Yu and Liang Zou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Yanni Wang

171 papers receiving 3.6k citations

Hit Papers

New insights into TGF-β/Smad signaling in tissue fibrosis 2018 2026 2020 2023 2018 2024 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanni Wang China 29 1.3k 564 479 416 366 186 3.7k
Cheng Wang China 37 1.5k 1.1× 403 0.7× 366 0.8× 458 1.1× 212 0.6× 220 4.4k
Zhe Feng China 33 1.3k 1.0× 580 1.0× 263 0.5× 334 0.8× 379 1.0× 150 3.4k
Mingming Liu China 29 1.2k 0.9× 246 0.4× 308 0.6× 299 0.7× 439 1.2× 220 3.3k
Hailin Zhao China 40 1.3k 1.0× 321 0.6× 471 1.0× 696 1.7× 366 1.0× 107 5.0k
Li Yang China 36 1.4k 1.1× 1.5k 2.7× 426 0.9× 385 0.9× 342 0.9× 172 4.5k
Jing Chen China 36 2.3k 1.8× 1.0k 1.8× 365 0.8× 220 0.5× 228 0.6× 187 4.6k
Xue Li China 28 772 0.6× 237 0.4× 478 1.0× 403 1.0× 323 0.9× 198 2.8k
Philippe Gillery France 38 981 0.8× 324 0.6× 331 0.7× 449 1.1× 228 0.6× 174 4.3k
Zhaohong Chen China 29 973 0.8× 966 1.7× 304 0.6× 275 0.7× 305 0.8× 97 2.7k
Fuu‐Jen Tsai Taiwan 35 1.6k 1.2× 199 0.4× 315 0.7× 343 0.8× 463 1.3× 275 4.2k

Countries citing papers authored by Yanni Wang

Since Specialization
Citations

This map shows the geographic impact of Yanni Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanni Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanni Wang more than expected).

Fields of papers citing papers by Yanni Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanni Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanni Wang. The network helps show where Yanni Wang may publish in the future.

Co-authorship network of co-authors of Yanni Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanni Wang. A scholar is included among the top collaborators of Yanni Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanni Wang. Yanni Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Guangwen, Xi Jiao, Yanshuo Cao, et al.. (2025). An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinoma. Cancer Immunology Immunotherapy. 74(4). 112–112. 1 indexed citations
2.
3.
Li, Daxiu, Jie Xiang, Yanni Wang, Yun Xiang, & Ruo Yuan. (2025). Target-initiated autocatalytic and concatenated DNAzyme/CHA amplification cascades for highly sensitive fluorescent detection of TET1 dioxygenase. Talanta. 293. 128114–128114. 1 indexed citations
5.
Ran, Ting, et al.. (2025). Gender-specific correlations between serum lipid profiles and intra-pancreatic fat deposition: a cross-sectional study. Lipids in Health and Disease. 23(1). 384–384. 2 indexed citations
6.
Mo, Xiaokui, Yanni Wang, Huan He, et al.. (2025). Design of photoactivatable methylene blue-bufalin conjugate for GPX4-targeted degradation to induce ferroptosis-like death in breast cancer therapy. Bioorganic Chemistry. 163. 108629–108629. 1 indexed citations
7.
Huang, Chengxiang, Xinhang Li, Jiang Zhou, et al.. (2024). Dual polarization in CoMoO4-NiMoO4 heterojunction boosted electrochemical charge storage. Acta Materialia. 281. 120419–120419. 6 indexed citations
8.
Hu, Nan, et al.. (2024). Electrical injuries in children—a 6-year retrospective study. Injury. 55(6). 111482–111482. 1 indexed citations
9.
Liu, Guiqing, et al.. (2024). Assessment of the Risk of Malnutrition or Frailty Among Patients Undergoing Liver Transplantation: A Hospital-Based Prospective Study. International Journal of General Medicine. Volume 17. 2347–2354. 1 indexed citations
10.
Li, Xiaojun, et al.. (2024). Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation. Frontiers in Pharmacology. 15. 1386604–1386604. 7 indexed citations
11.
Gong, Jian Ping, et al.. (2024). Identifying the risk of depression in a large sample of adolescents: An artificial neural network based on random forest. Journal of Adolescence. 96(7). 1485–1497. 7 indexed citations
12.
Wu, Xueying, Xi Jiao, Ying Hu, et al.. (2024). Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for ImmunoTherapy of Cancer. 12(2). e006616–e006616. 15 indexed citations
13.
Wang, Yanni, Guohua Li, Peiwu Qin, et al.. (2023). Executive functions in non-suicidal self-injury comorbid first-episode and drug-naïve depression among adolescents. Psychiatry Research. 328. 115476–115476. 8 indexed citations
14.
Fan, Hui, Yanni Wang, Li Su, et al.. (2023). Incomplete Knockdown of MyD88 Inhibits LPS-Induced Lung Injury and Lung Fibrosis in a Mouse Model. Inflammation. 46(6). 2276–2288. 7 indexed citations
15.
Wang, Yanni, et al.. (2022). Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease. Acta Pharmacologica Sinica. 44(2). 393–405. 49 indexed citations
16.
Chen, Yuanyuan, He-He Hu, Yanni Wang, et al.. (2020). Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights. Archives of Biochemistry and Biophysics. 695. 108623–108623. 13 indexed citations
17.
Wang, Yanni. (2018). Medical writing in China: Trends and opportunities. Medical Writing. 27. 60–63. 1 indexed citations
18.
Wang, Yanni, et al.. (2017). WWC3 Inhibits Glioma Cell Proliferation Through Suppressing the Wnt/β-Catenin Signaling Pathway. DNA and Cell Biology. 37(1). 31–37. 24 indexed citations
19.
Liu, Yongbing, et al.. (2013). Health literacy and social support in nursing homes. 7(5). 308–311. 1 indexed citations
20.
Wang, Yanni, et al.. (2006). The hemostasis effect on experimental mice of RVV-X from venom of Viper russellii in Guangxi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026